Health Personalised Vaccine Tested in Ovarian Cancer StudyCian ByrneOctober 16, 2026 A phase 1 trial in Nature Medicine found a personalised NeoVax vaccine with nivolumab is feasible and acceptably safe in platinum-sensitive ovarian cancer.
